Frankfurt - Delayed Quote EUR

Sinopharm Group Co. Ltd. (X2S.F)

2.0950
-0.0160
(-0.76%)
At close: May 20 at 8:08:35 AM GMT+2
Loading Chart for X2S.F
  • Previous Close 2.1110
  • Open 2.0950
  • Bid 2.0770 x 400000
  • Ask 2.1230 x 400000
  • Day's Range 2.0950 - 2.0950
  • 52 Week Range 1.8430 - 2.7170
  • Volume 8,445
  • Avg. Volume 1,093
  • Market Cap (intraday) 6.625B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 7.48
  • EPS (TTM) 0.2800
  • Earnings Date Apr 25, 2025
  • Forward Dividend & Yield 0.09 (4.09%)
  • Ex-Dividend Date Jun 16, 2025
  • 1y Target Est --

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

www.sinopharmgroup.com.cn

108,217

Full Time Employees

December 31

Fiscal Year Ends

Recent News: X2S.F

View More

Performance Overview: X2S.F

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

X2S.F
20.94%
HANG SENG INDEX (^HSI)
18.05%

1-Year Return

X2S.F
29.57%
HANG SENG INDEX (^HSI)
20.60%

3-Year Return

X2S.F
244.64%
HANG SENG INDEX (^HSI)
14.31%

5-Year Return

X2S.F
787.91%
HANG SENG INDEX (^HSI)
2.94%

Compare To: X2S.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: X2S.F

View More

Valuation Measures

Annual
As of 5/19/2025
  • Market Cap

    6.68B

  • Enterprise Value

    9.41B

  • Trailing P/E

    7.53

  • Forward P/E

    7.60

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.09

  • Price/Book (mrq)

    0.67

  • Enterprise Value/Revenue

    0.13

  • Enterprise Value/EBITDA

    3.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.22%

  • Return on Assets (ttm)

    2.60%

  • Return on Equity (ttm)

    8.24%

  • Revenue (ttm)

    578.9B

  • Net Income Avi to Common (ttm)

    7.09B

  • Diluted EPS (ttm)

    0.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.36B

  • Total Debt/Equity (mrq)

    61.08%

  • Levered Free Cash Flow (ttm)

    30.17B

Research Analysis: X2S.F

View More

Company Insights: X2S.F

Research Reports: X2S.F

View More

People Also Watch